Form 4 for SGHT Sight Sciences, Inc.
Accepted 2021-07-19 00:00:00 ET · period of report 2021-07-19 · accession 0000899243-21-028882 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2021-07-19 | 2021-07-19 | SGHT | Selnick Jesse | CFO | C - Cnv Deriv | — | +2.22M | 2.22M | New | — |
| DMI | 2021-07-19 | 2021-07-19 | SGHT | Selnick Jesse | CFO | C - Cnv Deriv | — | -1.11M | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-19 | C | A | 2,219,568 | — | 2,219,568 | I See footnote | — | — | (F1) The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. (F2) These shares are held of record by Sight Sciences Angels, LP ("Sight Sciences Angels"). The reporting person is a Managing Member of the General Partner of Sight Sciences Angels and may be deemed to beneficially own the shares of common stock held by Sight Sciences Angels. |
| 2 | Derivative | Series A Redeemable Convertible Preferred Stock | 2021-07-19 | C | D | 869,565 | — | 0 | I See footnote | — · — to — | 1,739,130 Common Stock | (F1) The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. (F2) These shares are held of record by Sight Sciences Angels, LP ("Sight Sciences Angels"). The reporting person is a Managing Member of the General Partner of Sight Sciences Angels and may be deemed to beneficially own the shares of common stock held by Sight Sciences Angels. |
| 3 | Derivative | Series C Redeemable Convertible Preferred Stock | 2021-07-19 | C | D | 121,725 | — | 0 | I See footnote | — · — to — | 243,450 Common Stock | (F1) The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. (F2) These shares are held of record by Sight Sciences Angels, LP ("Sight Sciences Angels"). The reporting person is a Managing Member of the General Partner of Sight Sciences Angels and may be deemed to beneficially own the shares of common stock held by Sight Sciences Angels. |
| 4 | Derivative | Series B Redeemable Convertible Preferred Stock | 2021-07-19 | C | D | 118,494 | — | 0 | I See footnote | — · — to — | 236,988 Common Stock | (F1) The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. (F2) These shares are held of record by Sight Sciences Angels, LP ("Sight Sciences Angels"). The reporting person is a Managing Member of the General Partner of Sight Sciences Angels and may be deemed to beneficially own the shares of common stock held by Sight Sciences Angels. |